All India Institute of Medical Sciences director Dr Randeep Guleria had said that the Bharath Biotech International limited’s Covaxin is likely to be approved for Children by September. “After the completion of the second and third phase of trials of Covaxin for children, the trial data would be made available by September and the vaccine itself is likely to be approved in the same month,” Dr Guleria told India Today. He added that the Pfizer-BioNTech shot, if approved in India, could be another alternative for children to be vaccinated with.

Leave a Reply

Your email address will not be published.